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Abstract Human satellite cells (SCs) are heterogeneous
with respect to markers for their identiﬁcation in the niche
between the muscle ﬁbre plasma membrane and its basal
lamina. We have previously shown that, in biopsies from
highly competitive power lifters, power lifters with long-
term use of anabolic steroids and a population of healthy
sedentary men, antibodies against the neuronal cell adhe-
sion molecule (NCAM) and the paired box transcription
factor Pax7 together label 94% of the SCs, NCAM alone
labels 4% and Pax7 alone labels 1%. In the present study,
we have further studied these biopsies with four markers
related to SC activation and differentiation. Our study
unequivocally shows that staining for MyoD and myogenin
are present in nuclei of SCs and of myoblasts and myotubes
in areas of muscle ﬁbre regeneration. Staining for c-Met
was observed in a proportion of Pax7
? SCs. However,
widespread labelling of the sarcolemma precluded the
quantiﬁcation of c-Met
?/Pax7
? SCs and the use of c-Met
as a reliable SC marker. Pax7
? SCs labelled by anti-Delta
like1 (Dlk1) were present in all samples but in variable
proportions, whereas muscle progenitor cells related to
repair were Dlk1
-. Staining for Dlk1 was also observed in
Pax7
- interstitial cells and in the cytoplasm of some small
muscle ﬁbres. Interestingly, the proportion of Dlk1
?/Pax7
?
SCs was signiﬁcantly different between the groups of
power lifters. Thus, our study conﬁrms that human SCs
show marked heterogeneity and this is discussed in terms
of SC activation, myonuclei turnover, muscle ﬁbre growth
and muscle ﬁbre damage and repair.
Keywords Skeletal muscle satellite cells   Myogenic
regulatory factors   Pax7   Dlk1/FA1   Strength training  
Anabolic steroids
Introduction
Satellite cells (SCs) have, since their identiﬁcation between
the muscle ﬁbre plasma membrane and its basal lamina,
traditionally been associated with muscle damage and
repair (Bischoff and Franzini-Armstrong 2004). However,
in the last decade, an additional focus has been made on
SCs as stem cells and candidates for cell-based therapies to
treat muscular dystrophies and other neuromuscular dis-
eases. This research on SC molecular and cellular biology
has been so far done mostly in vitro using cultured cells
and isolated muscle ﬁbres with adhering SCs, or in in vivo
studies on molecular engineered rodents (Amthor et al.
2006; Gnocchi et al. 2009; Nagata et al. 2006). Research on
human SCs in vivo has been focused on their relation to
ageing, exercise and growth (for reviews, see (Degens
2007; Eriksson 2006; Kadi et al. 2005; Snijders et al. 2009;
Thornell et al. 2003).
SCs were primarily only detectable with electron
microscopy, but can now be revealed at the light micro-
scopic level using immunohistochemistry. In human mus-
cle biopsies, antibodies against the adhesion molecules,
neural cell adhesion molecule (NCAM) and M-cadherin,
are widely used for SC identiﬁcation (Chariﬁ et al. 2003;
Crameri et al. 2007; 2004; Kadi 2000; Kadi et al. 2005;
1999a; Mackey et al. 2007a; Mackey et al. 2007b; Olsen
et al. 2006; Petrella et al. 2006; Reimann et al. 2004;
Renault et al. 2002; Sajko et al. 2004; Verney et al. 2008)
although they are not speciﬁc markers for SCs (Illa et al.
1992). In 2000, the transcription factor Pax7 was
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(Seale et al. 2000). However, in human muscle biopsies,
anti-Pax7 labels approximately 95% of all SCs in com-
parison to staining for M-cadherin (Reimann et al. 2004)o r
NCAM (Lindstrom and Thornell 2009). In our studies on
the trapezius muscle of power lifters and sedentary men,
the majority of SCs, 94.1%, were NCAM
? and Pax7
?,
whereas 4.7% were NCAM
? and Pax7
- and 1.2%
NCAM
- and Pax7
?. What this SC heterogeneity in human
muscle reﬂects is unknown, but might indicate that the SCs
are intrinsically different or that they are in different stages
of quiescence, activation or differentiation.
Myogenic speciﬁcation and differentiation of SCs in
mature muscle closely recapitulate foetal myogenesis and
are dependent on factors such as Myf5, MyoD, Mrf4 and
myogenin. These factors are collectively known as the
myogenic regulatory factors (MRFs). Expression of Myf5,
MyoD and Mrf4 are related to activation and proliferation
of SCs, whereas myogenin reﬂects terminal myoblast dif-
ferentiation (Kuang et al. 2007; Tajbakhsh 2009). Several
studies have aimed to study the expression of MyoD or
myogenin in human muscle, but to the best of our knowl-
edge, no study has shown their presence in SCs in vivo in
resting skeletal limb muscle nor after sessions of training or
bouts of intensive exercise (Crameri et al. 2007; 2004;
Dreyer et al. 2006; Kadi et al. 2004).
Rodent muscle studies have shown SC heterogeneity
based on different proliferative (Rantanen et al. 1995;
Rossi et al. 2010) and myogenic capacities (Rossi et al.
2010) or variability in the expression of different SC
markers (Beauchamp et al. 2000; Cornelison and Wold
1997; Holterman et al. 2007; Kuang et al. 2007). Based on
heterogeneous expression of Myf5, it is suggested that
mouse SCs are composed of two hierarchical subpopula-
tions identiﬁed as Pax7
? and Myf5
- stem cells (10%) and
Pax7
? and Myf5
? committed myogenic progenitor cells
(90%) (Kuang et al. 2007).
Delta like1 (Dlk1), also known as preadipocyte factor-1
(Pref-1) and pG2 (Lee et al. 1995), has also been related to
a subpopulation of SCs (Crameri et al. 2004; Mackey et al.
2007a; White et al. 2008). Dlk1 is a transmembrane protein
belonging to the epidermal growth factor (EGF)-like pro-
tein family that includes proteins containing tandem EGF
repeats in their extracellular domain (D’Souza et al. 2008).
The extracellular domain of Dlk1 can be proteolytically
released and is referred to as fetal antigen 1 (FA1) (Wang
and Sul 2006). Studies on human skeletal muscle using
antibodies against Dlk1 have shown that it is highly
expressed during muscle development and in muscle dis-
orders (Andersen et al. 2009). Reports on the presence of
Dlk1 in normal resting human muscle are highly divergent
and vary between being practically absent (Andersen et al.
2009; Crameri et al. 2004) to being present in SCs and in
cells located in between muscle ﬁbres (Mackey et al.
2007b). Furthermore, it is not fully understood how the
expression of Dlk1 is affected by exercise (Crameri et al.
2004; Mackey et al. 2007b).
c-Met, the receptor for hepatocyte growth factor (HGF),
is generally considered to be present on both quiescent and
activated SCs in rodents (Cornelison and Wold 1997;
Hawke and Garry 2001). c-Met has been used as a marker
for human myogenic cells in vitro (Ozeki et al. 2006) and
in vivo as a total SC marker (Antunes-Foschini et al. 2006;
De Luna et al. 2004), but knowledge on c-Met in human
skeletal muscle in trained subjects are lacking.
In the present study, we have further explored the het-
erogeneity of human SCs in the biopsies of power lifters,
power lifters using anabolic substances and control sub-
jects. Our newly developed multiple marker (MM) method
(Lindstrom and Thornell 2009) was used to compare
staining for MyoD, myogenin, c-Met and Dlk1 with
staining for NCAM or Pax7, which are the reference
markers of SCs.
Materials and methods
Biopsies from the descending part of the trapezius muscle
from 11 male power lifters and 6 healthy sedentary male
controls (C) were thoroughly investigated. Five of the
power lifters had never used anabolic drugs (P), whereas
six had used high doses of anabolic substances (PAS).
Vastus lateralis biopsies from the PAS subjects were also
used. For a full description of the participant elite power
lifters, their training regime and the substances used for
doping see Eriksson et al. (2005). Handling of biopsies and
their detailed analysis with respect to muscle ﬁbre types,
muscle ﬁbre area, muscle pathology and SC frequency
have been reported previously (Eriksson et al. 2005; Kadi
et al. 1999a; 1999b; Lindstrom and Thornell 2009). Written
consent in accordance with the World Medical Association
‘‘Declaration of Helsinki’’ was obtained from all the sub-
jects. The study was approved by the Ethical Committee of
Umea ˚ University.
Immunohistochemistry
Serial frozen muscle cross sections (5 lm) were prepared
as previously described (Lindstrom and Thornell 2009).
The primary antibodies used are listed in Table 1. SCs
were visualized using an MM protocol (Lindstrom and
Thornell 2009) or by double labelling of a single SC
marker (NCAM, Pax7, MyoD, myogenin, c-Met or Dlk1)
in combination with staining for the basal lamina (laminin
or laminin alpha 2 chain) or the myoﬁbre plasma mem-
brane (dystrophin) to discriminate between cells in the SC
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123niche from adjacent cells and myonuclei. For the MM
protocol, antibodies against NCAM or Pax7 were used as
the reference markers for SC identiﬁcation in combination
with antibodies against MyoD, myogenin, c-Met or the
transmembrane and extracellular (FA1) portion of Dlk1.
Bound primary antibodies were visualized by indirect
immunoﬂuorescence using afﬁnity-puriﬁed antibodies
speciﬁcally prepared for multiple labelling and conjugated
with ﬂuorescein (FITC), Rhodamine Red-X (RRX) or
Cyanine 5 (Cy5) (Jackson ImmunoResearch Laboratories
Inc., West Grove, PA, USA). Nuclei were identiﬁed with
40, 6-diamidino-2-phenylindole (DAPI) provided in the
mounting medium (Vectashield
, Vector Laboratories Inc.,
Burlingame, CA, USA). Control sections were treated
according to standard protocols except that the primary
antibody was omitted.
Light microscopy and analysis of immunostained
sections
The sections were evaluated using a Nikon eclipse E800
microscope (Nikon Inc., Melville, NY, USA) equipped
with ﬂuorescence ﬁlters for FITC (MBE34133), Texas Red
(MBE34172), FITC/Texas Red (MBE 34720), DAPI/FITC/
Texas Red (MBE34820) (Nikon Inc., Melville, NY, USA)
and Cy5 (HQ41008) (Chroma Technology Corp, Rock-
ingham, USA). A SPOT RT KE slider camera (6 mega-
pixel sampling) (Diagnostic Instruments Inc., Sterling
Heights, MI, USA) was used for image acquisition.
Stained cross sections were analysed using different
ﬁlter cubes and 209 and 409 objectives. High-resolution
digital images were captured to cover the whole or a sig-
niﬁcant part of a large section using the 209 objective and
used for detailed analysis and quantiﬁcation using the
Adobe Photoshop CS2 software (Adobe Systems Inc.,
Mountain View, CA, USA).
MyoD and myogenin-labelled SCs
For each subject, the number of SCs labelled by anti-MyoD
was quantiﬁed on three sections and SCs labelled by anti-
myogenin were counted on one section. The number of
muscle ﬁbres was counted on the section stained for MyoD
or myogenin in combination with staining for dystrophin.
Fibres with incomplete staining of the plasma membrane,
visualized by staining for dystrophin, were not included in
the analysis. The mean number of SCs per ﬁbre (total SCs/
ﬁbre), previously calculated for each subject (Lindstrom
and Thornell 2009) (i.e. all cells identiﬁed by their staining
for Pax7 and/or NCAM inside the basal lamina of the
myoﬁbres divided by the total number of analysed myoﬁ-
bres) was used to estimate the proportion of SCs labelled
by anti-MyoD and anti-myogenin. The following calcula-
tions were used: %MyoD
? SCs = [(number of MyoD
?
SCs/number of ﬁbres)/(total SCs/ﬁbre)] 9 100 and
%myogenin
? SCs = [(number of myogenin
? SCs/number
of ﬁbres)/(total SCs/ﬁbre)] 9 100.
Dlk1-stained SCs
The proportion of Pax7
? SCs labelled by anti-Dlk1 for each
subject was determined from all Pax7
? SCs identiﬁed in the
cross section stained for Pax7, Dlk1, laminin and DAPI.
Statistics
All statistical analyses were performed using SPSS stan-
dard Version 17.0 (SPSS, Chicago, Illinois, USA).
Table 1 Primary antibodies used
Primary antibody target Host species Company Catalogue number
Leu19/CD56/NCAM Mouse Beckton Dickinson, San Jose, CA, USA 347740
Pax7 Mouse Developmental Studies Hybridoma Bank, University of Iowa, USA PAX7
MyoD Mouse Dako, Glostrup, Denmark M3512
Myogenin Mouse Developmental Studies Hybridoma Bank, University of Iowa, USA F5D
c-Met Mouse Novocastra Laboratories Ltd., UK NCL-cMet
Dlk1 Rabbit Kindly provided by Profs C Harken Jensen and B Teisner, Odense, Denmark
Dystrophin Rabbit Gene Tex, Inc. GTX15277
Laminin Sheep The Binding Site Ltd., Birmingham, UK PC128
Laminin alpha 2 chain Mouse Novocastra Laboratories Ltd., UK NCL-Merosin
Nestin Mouse R&D Systems Inc. MAB1259
Vimentin Mouse Dako, Glostrup, Denmark M0725
Desmin Mouse Dako, Glostrup, Denmark M0760
Embryonic-MyHC Mouse Developmental Studies Hybridoma Bank, University of Iowa, USA F1.652
Foetal/perinatal-MyHC Mouse Novocastra Laboratories Ltd., UK NCL-MHCn
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123Residual analyses revealed no strong discrepancies from
the one-way analysis of variance (ANOVA) assumptions.
When the ANOVA test suggested statistical differences,
the Tukey post hoc test was applied.
A v
2 test was used to compare the counts of MyoD
? and
myogenin
? SCs. Statistical signiﬁcance was accepted at
p\0.05. Data are presented as means and standard
deviations.
Results
Staining for MyoD and myogenin
When using the MM method as previously described for
two SC markers from the same species, i.e. antibodies
against MyoD or myogenin applied as the second primary
antibody, after the cell surface marker anti-NCAM, we
noticed that staining for MyoD did not label any nuclei,
whereas the combination with anti-NCAM worked well for
labelling with anti-myogenin (Fig. 1). To overcome the
lack of staining for MyoD together with staining for
NCAM, analysis of new sections stained for MyoD only
was performed under the microscope before further label-
ling. If staining for MyoD was observed, the sections were
additionally labelled with anti-dystrophin and DAPI or
anti-laminin and DAPI. This combination of labelling
allowed us to examine whether MyoD-stained nuclei were
in a SC position or within the myoﬁbre plasma membrane,
or whether they belonged to another cell type (Fig. 2). No
nuclei labelled by anti-MyoD were observed outside the
basal lamina. Thus, a MyoD
? nucleus was identiﬁed as
belonging to a SC if it was observed outside the myoﬁbre
plasma membrane labelled by anti-dystrophin in otherwise
normal ﬁbres. To make sure that all nuclei at the periphery
of myoﬁbres labelled by anti-myogenin were also located
outside the myoﬁbre plasma membrane, additional adjacent
sections were stained for myogenin, dystrophin and DAPI
(Fig. 2). Interestingly, the staining for dystrophin was often
thinner in the area between the MyoD
? or the myogenin
?
SC and the myoﬁbre. Furthermore, a thin rim of staining
for dystrophin was often present exterior to the MyoD
? or
myogenin
? nucleus (Fig. 2).
Staining for MyoD and myogenin was unquestionably
present in some biopsies; however, the number of positive
nuclei was low (Table 2). MyoD
? SCs were found in four
of ﬁve individuals in the P group, three of ﬁve in the PAS
group and in two of ﬁve in the C group. The mean pro-
portion of MyoD
? SCs was slightly higher in the P group
(1.2% ± 1.9) compared to the C group (0.5% ± 0.8) and
the PAS group (0.5% ± 0.6). The proportion of MyoD
?
SCs in subjects with MyoD
?-stained SCs (9 out of 15)
ranged between 0.3 and 4.6%.
Myogenin
? SCs were found in two of ﬁve individuals in
the P group, in one of ﬁve in the PAS group and in three of
ﬁve in the C group. The mean proportion of myogenin
?
Fig. 1 Cross section from
trapezius muscle of a PAS
subject stained for NCAM,
myogenin, laminin and DAPI
shown in a merged image of all
markers in a. Two SCs are
encircled and shown in higher
magniﬁcation in single and
merged images (insets b–e and
f–i): b and f NCAM (green);
c and g NCAM
(green ? red = yellow) and
myogenin (red); d and h NCAM
(yellow), myogenin (red) and
DAPI (blue); e and i laminin
(white). Note the distinct
staining for myogenin in one of
the SC (upper circle).
b–e NCAM
?/myogenin
- SC
and f–i NCAM
?/myogenin
?
SC. Auto ﬂuorescent lipofuscin
granules are indicated with
small arrowheads in e and i.
Capillaries (asterisks).
Bar 20 lm
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123SCs was 0.9% ± 1.4 in the P group, 0.5% ± 0.5 in the C
group and 0.2% ± 0.4 in the PAS group. The proportion of
myogenin
? SCs in subjects with myogenin
? SCs (6 out of
15) ranged between 0.4 and 3.0%. No statistical difference
in the mean proportion of MyoD
? SCs or myogenin
? SCs
was found between the groups.
MyoD
? and/or myogenin
? nuclei were seen inside the
basal lamina of a few dystrophin negative myoﬁbres,
containing Pax7
? and NCAM
?, and Pax7
- and NCAM
?
cells and some macrophage nuclei (Figs. 3, 5g–o), as well
as in regenerating (NCAM
?) myoﬁbres (Figs. 4, 5a–f).
In one PAS subject, weak staining for MyoD and
myogenin was observed in the myonuclei of some myoﬁ-
bres with angular shape. On adjacent sections, these
myoﬁbres showed increased staining for nestin, but not for
other markers related to myoﬁbre regeneration such as
NCAM or developmental MyHC isoforms (Fig. 6). Inter-
estingly, the staining for MyoD or myogenin observed in
these myonuclei was obviously weaker than the nuclear
staining for MyoD or myogenin in SCs and in regenerating
ﬁbres (compare Figs. 1–5 with 6).
Staining for Dlk1
Using the MM method, sections were labelled by either
anti-Pax7 or anti-NCAM for SC identiﬁcation together
with staining for Dlk1, laminin and DAPI. The staining for
Dlk1 was found on the SC plasma membrane and/or their
cytoplasm (Fig. 7a–e) and showed that a subpopulation of
SCs were Dlk1
?. Both Pax7
? and Dlk1
?, and Pax7
? and
Dlk1
- SCs were observed in the same myoﬁbre and cross
section (Fig. 7d–e). We could exclude the presence of
Pax7
- and Dlk1
? cells inside the basal lamina of myoﬁbres
labelled by anti-laminin (Fig. 7f–i). The subpopulation of
SCs labelled by anti-Dlk1 did not mirror the positive
staining for MyoD or myogenin. For all subjects, a total
number of 22 MyoD
? SCs were identiﬁed on sections also
stained for Dlk1, laminin and DAPI. Of the MyoD
? SCs,
64% were Dlk1
? and 36% were Dlk1
-.
Muscle progenitor cells Pax7
? and NCAM
?, Pax7
- and
NCAM
?, MyoD
? or myogenin
? inside the basal lamina of
some dystrophin negative myoﬁbres or regenerating
NCAM
? myoﬁbres were not labelled by anti-Dlk1.
Fig. 2 Cross sections from
trapezius muscle of C, P and
PAS subjects stained for MyoD
or myogenin, dystrophin and
DAPI to examine whether anti-
MyoD and/or anti-myogenin
labels SCs (i.e. nuclei located
exterior to the staining for
dystrophin of myoﬁbres) and/or
myonuclei (i.e. nuclei interior of
the staining for dystrophin).
a–c (PAS subject), d–f (P
subject) and g–i (C subject)
three MyoD
? nuclei located in a
SC position exterior to the
myoﬁbre plasma membrane.
Note also the MyoD
- nucleus in
a SC position (arrowheads a–c).
j–l (C subject) and m–o
(P subject) two myogenin
?
nuclei located in a SC position
exterior to the myoﬁbre plasma
membrane. Note in n, the
myonucleus (N) not labelled by
anti-myogenin. In j–l weak
staining for anti-dystrophin is
seen on both sides of the
myogenin
? nucleus. Note the
variability of anti-dystophin
labelling on the outside of the
MyoD
? and myogenin
? nuclei.
A thin rim is evident in g–i and
j–l. Arrows show the thin rim of
staining for dystrophin interior
to (f) and around (i and l) the
SCs. Bar 10 lm
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123(Figs. 3j–l, 4j–l and 5m–o). Staining of Dlk1 in mononu-
clear cells and cell structures within the endomysium, i.e.
outside the muscle ﬁbre basal lamina, was observed. These
cells were negative for antibodies against Pax7, NCAM or
MyoD and were not labelled by anti-laminin (Fig. 7f–i).
They were in general few in both power lifters and sed-
entary subjects. However, in one sedentary subject, more
interstitial cells labelled by anti-Dlk1 were seen close to
the area of some regenerating myoﬁbres.
In addition, occasional myoﬁbres with small cross-sec-
tional area showed staining for Dlk1 in their cytoplasm.
The staining was stronger close to the nucleus in some of
these ﬁbres. Such myoﬁbres were also labelled by anti-
NCAM and observed in both power lifter and sedentary
subjects (Fig. 8). However, as already stated above, the
majority of NCAM
? myoﬁbres as well as NCAM
?
regenerating ﬁbres were Dlk1
-. Notably, some intrafusal
ﬁbres were also labelled by anti-Dlk1 (not shown).
Proportion of Dlk1
?/Pax7
? SCs
In the C group, 72% ± 19 (range 44.4–90.5%) of the
Pax7
? SCs were Dlk1
? (Table 2). The largest proportion
of Dlk1
?/Pax7
? SCs, 85% ± 8 (range 72.5–91.6%), was
found in the P group, whereas the lowest proportion,
45% ± 25 (range 14.8–76.4%), was observed in the PAS
group. No statistical difference was observed between the
C group and either of the P or PAS groups, whereas the
proportion of Dlk1
?/Pax7
? SCs was signiﬁcantly elevated
in the P group compared to the PAS group (p = 0.01).
Interestingly, in the PAS group, the proportion of
Dlk1
?/Pax7
? SCs was B42% in four of six individuals.
Three of these four power lifters had used combinations of
testosterone, anabolic steroids and IGF-1 (PAS1, PAS2,
PAS5) and one had used testosterone (PAS6). The other
PAS subjects had reported intake of testosterone and ana-
bolic steroids (PAS3, PAS7). To further investigate whe-
ther the proportion of Dlk1
?/Pax7
? SCs was inﬂuenced by
the nature of their intake of anabolic drugs (IGF-1), and
assuming a similar effect on other muscles, biopsies from
the vastus lateralis muscle were also analysed. The mean
proportion of Dlk1
?/Pax7
? SCs was 70% ± 25 (range
23–92%). A low proportion of Dlk1
?/Pax7
? SCs in the
vastus lateralis muscle similar to that observed in the tra-
pezius muscle was only observed in one of the four PAS
subjects (PAS1) (Table 3).
Table 2 The proportions of satellite cells stained by NCAM, Pax7, MyoD, myogenin and Dlk1
Group Subject NCAM, Pax7, laminin and DAPI Pax7, Dlk1, laminin and DAPI
Number
of SCs
% NCAM
1/
Pax7
1 of total
SCs
% NCAM
1/
Pax7
2 of total
SCs
% NCAM
2/
Pax7
1 of total
SCs
% MyoD
1
of total SCs
% Myogenin
1
of total SCs
Number of
Pax7
1SCs
% Dlk1
1
of total
Pax7
1SCs
C 1 44 95.5 4.5 0 Na Na 63 90.5
4 73 95.9 2.7 1.4 0.89 0.76 135 54.8
5 92 88 8.7 3.3 0 0 72 44.4
6 97 94.8 3.1 2.1 0 0 172 76.0
7 139 95.0 4.3 0.7 0 0.36 248 88.3
8 88 92 5.7 2.3 1.84 1.19 212 76.9
Mean ± SD 76 ± 35 94.1 ± 3.6 4.3 ± 2.5 1.6 ± 1.2 0.5 ± 0.8 0.5 ± 0.5 150 ± 75 71.8 ± 18.5
P 2 62 87.1 1.6 11.3 0.52 0 76 90.8
3 62 98.4 1.6 0 0.46 0 109 72.5
4 120 100 0 0 0 0 154 91.6
5 83 96.4 3.6 0 0.45 1.35 93 89.2
9 68 92.6 5.9 1.5 4.58 3.05 86 80.2
Mean ± SD 79 ± 24 94.9 ± 5.2 2.5 ± 2.3 2.6 ± 4.9 1.2 ± 1.9 0.9 ± 1.4 104 ± 31 84.9 ± 8.3
PAS 1 36 100 0 0 Na Na 59 25.4
2 79 91.2 8.9 0 1.49 0.9 130 36.9
3 161 91.3 8.7 0 0 0 106 76.4
5 97 95.9 4.1 0 0.6 0 139 41.7
6 29 96.3 3.5 0 0 0 108 14.8
7 116 92.2 6.9 0.9 0.31 0 245 74.7
Mean ± SD 86 ± 50 94.5 ± 3.5 5.4 ± 3.5 0.2 ± 0.4 0.5 ± 0.6 0.2 ± 0.4 131 ± 62 45.0 ± 25.0*
The abbreviation (*) means signiﬁcantly different (p = 0.01) from the P group
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The MM method was used to evaluate the staining for
c-Met in SCs identiﬁed by anti-Pax7 and for some control
subjects also in combination with staining for Dlk1, lami-
nin and DAPI.
Anti-c-Met obviously labelled more cell structures than
SCs. On the basis of co-staining for Pax7, we could observe
that some SCs were undoubtedly c-Met
?, whereas others
were clearly c-Met
- (Fig. 9). However, without co-staining
for an additional SC marker and the basal lamina, it would
have been impossible to judge the c-Met
? labelling as a
marker for some SCs. Furthermore, we observed rare cases
of Pax7
? and c-Met
?-stained cells with a basal lamina of
theirown(Fig. 9).Themainproblemwasthatstainingforc-
Metwasalsoregularlyseenattheperipheryofthemyoﬁbres
and accumulated close to myonuclei (Fig. 10). This made
quantiﬁcation of the number of c-Met
?/Pax7
? SCs impos-
sible to carry out in a reliable way, as it was not always clear
whether the staining for c-Met was related to the Pax7
? SC
or to the myoﬁbre plasma membrane. In addition, staining
for c-Met was also seen in small blood vessels and in
mononuclear cells located between the myoﬁbres. These
cells were sometimes increased close to myoﬁbres with
signs of injury and repair and were not labelled by anti-Pax7
or anti-laminin (not shown). Some c-Met
? cells present
between the myoﬁbres were observed to co-stain for Dlk1,
but the majority were Dlk1
- (not shown).
Fig. 3 Necrotic myoﬁbre under
early repair, from trapezius
muscle of a PAS subject, shown
in serial muscle cross sections.
A number of NCAM
? cells are
seen inside the myoﬁbre basal
lamina. Some of these cells are
labelled by antibodies against
Pax7, MyoD or myogenin, but
none by anti-Dlk1. Sets of
arrows in the same position
(a–f and g–l, respectively)
indicate what we believe to be
the same nucleus in two serial
sections (a–c is adjacent to
d–e and g–i is adjacent to j–l).
Note the presence of an intact
basal lamina (e–f) around the
muscle ﬁbre under repair and
lack of plasma membrane
visualized by lack of staining
for dystrophin (h–i). a–c Note
NCAM
? and Pax7
? SC
(arrowhead) and in j–
l MyoD
-/Dlk1
? SC
(arrowhead). Bar 50 lm. The
cell and images depicted in
a–c, stained for NCAM, Pax7,
DAPI and laminin have been
published previously in
Lindstrom and Thornell (2009)
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123Discussion
Our multiple label method has made it possible to explore
how MyoD, myogenin, Dlk1 and c-Met are related to SCs
in situ in human limb muscle.
MyoD and myogenin in human skeletal muscle
This is the ﬁrst report on human limb skeletal muscle
where staining for MyoD and myogenin is unequivocally
shown in the nuclei of SCs in vivo. This was accomplished
by using the multiple label method comparing the staining
patterns for MyoD, myogenin, NCAM, dystrophin and
laminin. Thereby, it was possible to distinguish MyoD
? or
myogenin
? SCs in situ from myonuclei labelled by these
markers. Importantly, we did not observe staining for
MyoD and myogenin in myonuclei in normal muscle ﬁbres
in any of the sedentary or strength trained subjects. This is
in contrast to a previous study where staining for myogenin
was seen in myonuclei, but not in SCs after exercise (Kadi
et al. 2004). As expected, MyoD
? and myogenin
? nuclei
were also present in ﬁbres under repair.
Fig. 4 Serial muscle cross
sections from trapezius muscle
of a PAS subject. a–c Stained
for NCAM, Pax7, laminin and
DAPI. a Two Pax7
? nuclei
judged as SCs are marked
(arrows). d–f Stained for
MyoD, laminin and DAPI. Note
the presence of three MyoD
?
nuclei in the myoﬁbre (arrow in
d) strongly labelled by anti-
NCAM (compare with a).
g–i Stained for myogenin,
dystrophin and DAPI. The
strong NCAM
? myoﬁbre is
only partly and weakly labelled
by anti-dystrophin (arrow).
j–l Stained for MyoD, Dlk1,
laminin and DAPI. The strong
NCAM
? myoﬁbre has a
MyoD
? nucleus and is not
labelled by anti-Dlk1, whereas
faint staining for Dlk1 is seen in
the abnormal NCAM
? and
dystrophin
? myoﬁbre
formation at the top of the
images (arrowheads). The
staining for Dlk1 is more
distinct close to the nucleus.
Capillaries (asterisks).
Bar 20 lm
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123As MyoD is the hallmark for myogenic activation and
proliferation, and myogenin is a marker for terminal differ-
entiation of myoblasts (Zammit 2008), the MyoD
? SCs
might reﬂect a time point of increase in the number of SCs,
whereas myogenin
? SCs might be on their way to be
incorporated in the muscle ﬁbre and reﬂect a forthcoming
increase or turnover of myonuclei. The power lifters we
studiedwhohadperformedheavyresistancestrengthtraining
for years, some also using anabolic steroids, had increased
their pool of SCs by 50% compared to untrained sedentary
controls (Lindstrom and Thornell 2009). Importantly, in
these physically active power lifters, we observed that the
increased number of SCs was balanced with an increased
number of myonuclei acquired during myoﬁbre hyperthro-
phy (Lindstrom and Thornell 2009). Because the vast
majority of SCs were in a MyoD
- and myogenin
- quiescent
state similar to untrained sedentary subjects, we conclude
that a steady state level of SC activation, not different from
normally active subjects, was reached in these power lifters.
Our present results suggest that the myogenin
? SCs, and also
Fig. 5 Serial muscle cross
sections from trapezius muscle
of a PAS subject. Two different
areas are shown: (a–f) and
(g–o). Note a myoﬁbre partly
labelled by anti-NCAM
containing central nuclei and
having a cluster of nuclei
(arrowheads) within its basal
lamina. Two NCAM
? and
Pax7
? cells (arrows), judged as
muscle progenitor cells, are
present close to the basal lamina
in the cluster of nuclei
interpreted to represent
macrophages. d–f Three
myogenin
? internal myonuclei
are seen (d–e) in the part of the
myoﬁbre labelled by anti-
NCAM in a–b and which also
shows distinct staining for
dystrophin. The nuclei in the
cluster of mononuclear cells are
not labelled by anti-myogenin
and the area lacks a distinct
staining for dystrophin. g–i Two
NCAM
? small muscle ﬁbre
proﬁles are indicated with
arrowheads. Note the Pax7
?
nucleus (arrows) representing
the presence of a muscle
progenitor cell. j–l The smallest
myoﬁbre shows distinct staining
for dystrophin, whereas the
other lacks staining for
dystrophin (arrowheads) and is
now seen as a cluster of nuclei,
one of which is labelled by anti-
myogenin (arrows). m–o The
small ﬁbre is weakly stained for
Dlk1 (arrowhead), whereas a
MyoD
? and Dlk1
- nucleus is
seen in the larger of the two
small muscle ﬁbre proﬁles
(arrow). Bar 20 lm
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123to some extent MyoD
? SCs, fall within the subpopulation of
SCs, which were NCAM
? and Pax7
- (approximately 5% of
the SCs (Table 2)) (Lindstrom and Thornell 2009) This
conclusion is supported by: (1) cell culture studies showing
that Pax7 is down-regulated and not expressed together with
myogenin upon myogenic differentiation (Olguin and Olwin
2004; Reimann et al. 2004) and (2) that in multiple labelled
sections for NCAM, Pax7, myogenin, laminin and DAPI of
Duchenne muscular dystrophy muscle biopsies, many
NCAM
? and Pax7
- SCs were clearly labelled by anti-
myogenin, whereas still some NCAM
? SCs were not label-
led by either anti-Pax7 or anti-myogenin (Lindstro ¨m 2009).
Interestingly in our study, the subsarcolemmal cyto-
skeleton, as shown by staining for dystrophin, differed at
the site of contact between MyoD
? and myogenin
? SCs
and the muscle ﬁbre. Undoubtedly, this area is of special
importance for the fusion or signalling between the muscle
ﬁbre and the SC (Boonen and Post 2008; Cosgrove et al.
2009; Kuang et al. 2008; Lutolf et al. 2009). Whether the
thinner staining for dystrophin reﬂects (1) an adaptation
before the fusion of these myoblasts and the muscle ﬁbre or
(2) different amounts of protein in general at the SC niche,
has to await further studies. On the other hand, staining for
dystrophin on both sides of a SC might suggest its sepa-
ration from the myoﬁbre.
Dlk1
Our study unequivocally shows that anti-Dlk1 marks a
considerable proportion of SCs in regular power lifters and
sedentary men, although with large inter-individual
variations.
The reliability of our identiﬁcation of the Dlk1
? cells as
SCs is evidenced by the co-localization of staining for Pax7
and nuclei inside the myoﬁbre basal lamina and that both
Dlk1
? and Dlk1
- SCs were present even within the same
muscle ﬁbre proﬁle. Both quiescent and activated (MyoD
?)
SCs were either Dlk1
? or Dlk1
-. However, staining for
Dlk1 was also observed in the cytoplasm of some small
muscle ﬁbres and in mononuclear cells present in the
extracellular matrix (ECM) in conformity with previous
studies (Andersen et al. 2009; Mackey et al. 2007b).
The highest mean proportion of Dlk1
?/Pax7
? SCs and
the lowest variability was found in the P group. The PAS
group had signiﬁcantly lower proportion of Dlk1
?/Pax7
?
SCs compared to the P group. As four of six subjects in the
PAS group had distinctly lower values (41.7–14.8%)
compared to C ([44%) and P ([72%) subjects, we decided
to analyse also the biopsies, obtained at the same time,
from the vastus lateralis muscle of the PAS subjects. The
purpose was to answer whether the intake of steroids has a
general effect on the proportion of Dlk1
?/Pax7
? SCs. As
no correlation was observed, the prediction was rejected.
One possible explanation for the divergent results might be
that trapezius and vastus lateralis muscles respond differ-
ently to anabolic steroids due to their different numbers of
androgen receptors (Eriksson 2006).
The evaluation of Dlk1 expression in adult human
skeletal muscle has so far revealed very different results. In
normal and resting skeletal muscle, Dlk1 is reported to be
Fig. 6 Serial cross sections
from trapezius muscle of a PAS
subject. Two ﬁbres with angular
shape are shown in a–d and e–h,
respectively. All myonuclei in
the angulated ﬁbres show a
weak staining for both MyoD
(a, arrows) and myogenin (e,
arrows). The sarcoplasm stained
for nestin (c and g), but did not
stain for NCAM (d) or foetal–
perinatal-MyHC (h). Bar 50 lm
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123Fig. 7 Cross sections from
trapezius muscle stained for
Pax7, Dlk1, laminin and DAPI.
Three SCs (arrows a–c) labelled
by anti-Pax7 (a), contain a
nucleus (b) and are present
beneath the basal lamina (c).
One SC is Dlk1
-, whereas the
other two are Dlk1
? but to
different degrees (a–b),
(C subject). d Two Pax7
? SCs
are seen in the same myoﬁbre
(arrows in d–e), only one is
labelled by anti-Dlk1 (PAS
subject). f–h A Dlk1
? cell is
seen in the endomysium
between two myoﬁbres. This
cell is not labelled by anti-Pax7.
Two capillaries are marked
(asterisk) (C subject).
Bars 20 lm
Fig. 8 Two serial cross sections from trapezius muscle of a PAS
subject. a and c stained for MyoD, Dlk1, laminin and DAPI; b and
d stained for NCAM, Pax7, laminin and DAPI. Merged images of all
markers are shown to illustrate co-staining for Dlk1 and NCAM in
some small-sized myoﬁbres. One small-sized myoﬁbre in a and b and
several small-sized myoﬁbres in c and are stained for Dlk1 and
NCAM. One ﬁbre in c shows intense staining for Dlk1. Staining for
MyoD was not seen in these ﬁbres. SCs are indicated with arrowheads
in (b) and (d). Bar 20 lm
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123practically absent (Andersen et al. 2009; Crameri et al.
2004), or to be expressed by the majority of SCs and by
interstitial cells (Mackey et al. 2007b and the present
study). In response to one bout of unaccustomed eccentric
exercise, the proportion of Dlk1
? mononuclear cells/
myonuclei was highly increased (Crameri et al. 2004),
whereas the proportion of Dlk1
?/NCAM
? SCs remained
unchanged in response to a 36-km run (Mackey et al.
2007b). The proportion of Dlk1
?/NCAM
? SCs in the
endurance trained athletes was signiﬁcantly lower com-
pared to untrained individuals (48% ± 18 vs. 73% ± 12)
(Mackey et al. 2007b), whereas the group of regular power
Table 3 Comparison of the proportion of Dlk1/Pax7-stained satellite cells in the trapezius and vastus lateralis muscles of power lifters with
reported intake of anabolic substances
Trapezius Vastus lateralis
Group Subject Number of Pax7
1 SCs % Dlk1
1 of total Pax7
1 SCs Number of Pax7
1 SCs % Dlk1
1 of total Pax7
1 SCs
PAS 1 59 25.4 43 23.3
2 130 36.9 87 92.0
3 106 76.4 26 65.4
5 139 41.7 87 85.1
6 108 14.8 112 68.8
7 245 74.7 136 85.3
Mean ± SD 131 ± 62 45.0 ± 25.0 82 ± 41 69.9 ± 25.1
Fig. 9 Cross sections from
trapezius muscle stained for
c-Met, Pax7, laminin and DAPI.
a–d Two Pax7
? SCs are not
labelled by anti-c-Met (arrows).
e–h One Pax7
? SC shows
staining for c-Met close to the
nucleus. i–l A Pax7
? SC with a
large nucleus is clearly labelled
by anti-c-Met. m–p A Pax7
?
muscle progenitor cell shows
weak staining for c-Met and
distinct staining for laminin.
Bar 10 lm
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123lifters in our study instead indicated a higher proportion of
Dlk1
?/Pax7
? SCs compared to untrained individuals
(85% ± 8 vs. 72% ± 19). This difference may reﬂect that
during normal conditions, long-term strength training and
endurance training induce factors with different effects on
Dlk1 expression and Dlk1-mediated effect on SC
regulation.
In the present study, a few small Dlk1
? myoﬁbres were
present. Previously, Dlk1
? ﬁbres were only seen in muscle
biopsies of patients with DMD or Becker muscular dys-
trophy. Dlk1
? myotubes during muscle development and
Dlk1
? ﬁbres in dystrophic muscle were suggested to reﬂect
the immaturity of these ﬁbres (Andersen et al. 2009).
Remarkably, in our study, other immature ﬁbres (i.e.
Figs. 3, 4 and 5g–o) with signs of early repair were Dlk1
-.
Taken together, these ﬁndings urge the need for further
investigations of the temporal aspects of Dlk1 expression
in muscle regeneration.
In both power lifters and sedentary subjects, interstitial
staining for Dlk1 was modest and Dlk1
? mononuclear cells
in the ECM were not labelled by antibodies against Pax7,
MyoD or NCAM. Collectively, our results using the MM
method and other recent studies (Andersen et al. 2009;
Mackey et al. 2007b; Uezumi et al. 2010) clearly separate
Dlk1
? SCs and Dlk1
? interstitial cells as two distinct cell
types. The heterogeneous labelling by anti-Dlk1 on SCs
and other cells in the ECM under different conditions
indicates that Dlk1 has profound biological signiﬁcance
and should be considered in further studies.
c-Met
c-Met and HGF are generally considered to be part of the
cascade of signalling pathways, which lead to activation of
skeletal muscle SCs upon stretch or injury (Wozniak and
Anderson 2005; Wozniak et al. 2005). Our study showed
that antibodies against c-Met mark a small proportion of
human SCs, but also the muscle ﬁbre cell membrane and
interstitial cells. If we had not been able to verify the true
identity of SCs, by using Pax7 as SC marker, it would have
been impossible to distinguish with certainty whether some
of the SCs actually were labelled by anti-c-Met. Thus, we
conclude that c-Met is a more widespread receptor than
expected in human muscle, as it was not conﬁned to SCs
only, thereby excluding c-Met as a total marker for SCs
(De Luna et al. 2004; Pawlikowski et al. 2009). Our results
also prove that SCs in human muscle are heterogeneous
with respect to staining for c-Met. The staining of myoﬁ-
bres was most prominent in some biopsies of the power
lifters and might suggest some inﬂuence of exercise on
c-Met expression. Further studies are needed to clarify the
distribution of c-Met in human muscle and its relation to
exercise.
We conclude that the method used to visualize human
SCs in vivo matters. Our approach using multiple labels of
proteins in the same tissue section showed that human SCs
are more heterogeneous than previously recognized.
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